Suppr超能文献

如果单纯疱疹病毒US11蛋白在蛋白激酶R激活之前就已存在,它可通过阻止蛋白激酶R及其真核翻译起始因子2α亚基的磷酸化,有效补偿γ1(34.5)基因。

The herpes simplex virus US11 protein effectively compensates for the gamma1(34.5) gene if present before activation of protein kinase R by precluding its phosphorylation and that of the alpha subunit of eukaryotic translation initiation factor 2.

作者信息

Cassady K A, Gross M, Roizman B

机构信息

The Marjorie B. Kovler Viral Oncology Laboratories, The University of Chicago, Chicago, Illinois 60637, USA.

出版信息

J Virol. 1998 Nov;72(11):8620-6. doi: 10.1128/JVI.72.11.8620-8626.1998.

Abstract

In herpes simplex virus-infected cells, viral gamma134.5 protein blocks the shutoff of protein synthesis by activated protein kinase R (PKR) by directing the protein phosphatase 1alpha to dephosphorylate the alpha subunit of eukaryotic translation initiation factor 2 (eIF-2alpha). The amino acid sequence of the gamma134.5 protein which interacts with the phosphatase has high homology to a domain of the eukaryotic protein GADD34. A class of compensatory mutants characterized by a deletion which results in the juxtaposition of the alpha47 promoter next to US11, a gamma2 (late) gene in wild-type virus-infected cells, has been described. In cells infected with these mutants, protein synthesis continues even in the absence of the gamma134.5 gene. In these cells, PKR is activated but eIF-2alpha is not phosphorylated, and the phosphatase is not redirected to dephosphorylate eIF-2alpha. We report the following: (i) in cells infected with these mutants, US11 protein was made early in infection; (ii) US11 protein bound PKR and was phosphorylated; (iii) in in vitro assays, US11 blocked the phosphorylation of eIF-2alpha by PKR activated by poly(I-C); and (iv) US11 was more effective if present in the reaction mixture during the activation of PKR than if added after PKR had been activated by poly(I-C). We conclude the following: (i) in cells infected with the compensatory mutants, US11 made early in infection binds to PKR and precludes the phosphorylation of eIF-2alpha, whereas US11 driven by its natural promoter and expressed late in infection is ineffective; and (ii) activation of PKR by double-stranded RNA is a common impediment countered by most viruses by different mechanisms. The gamma134.5 gene is not highly conserved among herpesviruses. A likely scenario is that acquisition by a progenitor of herpes simplex virus of a portion of the cellular GADD34 gene resulted in a more potent and reliable means of curbing the effects of activated PKR. US11 was retained as a gamma2 gene because, like many viral proteins, it has multiple functions.

摘要

在单纯疱疹病毒感染的细胞中,病毒γ134.5蛋白通过引导蛋白磷酸酶1α使真核翻译起始因子2(eIF-2α)的α亚基去磷酸化,从而阻断活化蛋白激酶R(PKR)介导的蛋白质合成关闭。与该磷酸酶相互作用的γ134.5蛋白的氨基酸序列与真核蛋白GADD34的一个结构域具有高度同源性。已描述了一类补偿性突变体,其特征是发生缺失,导致在野生型病毒感染的细胞中,α47启动子与γ2(晚期)基因US11相邻并置。在感染这些突变体的细胞中,即使没有γ134.5基因,蛋白质合成仍能继续。在这些细胞中,PKR被激活,但eIF-2α未被磷酸化,且磷酸酶未被重新引导去使eIF-2α去磷酸化。我们报道如下:(i)在感染这些突变体的细胞中,US11蛋白在感染早期产生;(ii)US11蛋白与PKR结合并被磷酸化;(iii)在体外试验中,US11阻断了聚肌胞苷酸(poly(I-C))激活的PKR对eIF-2α的磷酸化作用;(iv)如果在PKR被poly(I-C)激活期间存在于反应混合物中,US11比在PKR被poly(I-C)激活后添加更有效。我们得出以下结论:(i)在感染补偿性突变体的细胞中,感染早期产生的US11与PKR结合并阻止eIF-2α的磷酸化,而由其天然启动子驱动并在感染后期表达的US11则无效;(ii)双链RNA对PKR的激活是大多数病毒通过不同机制应对的常见障碍。γ134.5基因在疱疹病毒中并非高度保守。一种可能的情况是,单纯疱疹病毒的祖先获得了细胞GADD34基因的一部分,从而产生了一种更有效、更可靠的抑制活化PKR作用的方法。US11作为γ2基因被保留下来,因为它与许多病毒蛋白一样,具有多种功能。

相似文献

7
Activation of NF-kappaB in cells productively infected with HSV-1 depends on activated protein kinase R and plays no apparent role in blocking apoptosis.
Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12408-13. doi: 10.1073/pnas.2034952100. Epub 2003 Oct 6.

引用本文的文献

2
Advanced progress in the genetic modification of the oncolytic HSV-1 virus.
Front Oncol. 2025 Jan 21;14:1525940. doi: 10.3389/fonc.2024.1525940. eCollection 2024.
3
Host species-specific activity of the poxvirus PKR inhibitors E3 and K3 mediate host range function.
J Virol. 2024 Nov 19;98(11):e0133124. doi: 10.1128/jvi.01331-24. Epub 2024 Oct 31.
4
Protein phosphatase 1 suppresses PKR/EIF2α signaling during human cytomegalovirus infection.
J Virol. 2024 Nov 19;98(11):e0059024. doi: 10.1128/jvi.00590-24. Epub 2024 Oct 29.
5
Strategies for engineering oncolytic viruses to enhance cancer immunotherapy.
Front Pharmacol. 2024 Sep 6;15:1450203. doi: 10.3389/fphar.2024.1450203. eCollection 2024.
6
Discovery of a Novel Intron in US10/US11/US12 of HSV-1 Strain 17.
Viruses. 2023 Oct 25;15(11):2144. doi: 10.3390/v15112144.
8
Herpes simplex virus 1 as an oncolytic viral therapy for refractory cancers.
Front Oncol. 2022 Jul 27;12:940019. doi: 10.3389/fonc.2022.940019. eCollection 2022.
9
Oncolytic HSV: Underpinnings of Tumor Susceptibility.
Viruses. 2021 Jul 20;13(7):1408. doi: 10.3390/v13071408.
10
The Race between Host Antiviral Innate Immunity and the Immune Evasion Strategies of Herpes Simplex Virus 1.
Microbiol Mol Biol Rev. 2020 Sep 30;84(4). doi: 10.1128/MMBR.00099-20. Print 2020 Nov 18.

本文引用的文献

3
Herpes simplex virus Us11 protein enhances recovery of protein synthesis and survival in heat shock treated HeLa cells.
Cell Stress Chaperones. 1997 Jun;2(2):119-31. doi: 10.1379/1466-1268(1997)002<0119:hsvupe>2.3.co;2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验